Next-Generation Cancer Diagnostics: Technologies and Global Markets

Single User License: $2750 Member Price: FREE Buy Now

• Membership Options

Report Highlights

The total global annual market for next generation cancer diagnostics was $776 million in 2010, and is growing at a compound annual growth rate (CAGR) of 47%, to reach a forecast market size of $5.3 billion in 2015.

Report Scope

The study scope includes the major next generation formats that are likely to become commercialized within the next 5 years.  Each technology format is analyzed to determine its market status, impact on future market segments, and projected growth from 2010 through 2015.  Technology issues and forces driving the market are discussed. 

Influencing factors, including cancer diagnostics needs, regulatory trends, industry structure, and patent status are also discussed.

BCC examines companies in the industry, corporate alliances, and assay consumption by indication.  We profile 108 companies participating in the industry.

Analyst Credentials

John Bergin has held business development, sales and marketing positions with a Fortune 500 advanced materials company, as well as executive management positions with a nanotechnology/separations company. Bergin holds a B.S. degree in Chemistry, an M.S. degree in Biotechnology and a Master of Business Administration. John Bergin is a pseudonym of the author.

• Bioprinting: Technologies and Global Markets (BIO148A).
• Liquid Biopsy Tools, Services and Diagnostics (BIO150A).
• DNA Sequencing: Emerging Technologies and Applications (BIO045F)
• Next Generation Sequencing: Emerging Clinical Applications and Global Markets (BIO126B)